Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus

Pol J Pharmacol. 1997 Nov-Dec;49(6):495-7.

Abstract

Effects of repeated imipramine treatment on inositol phosphates accumulation and on the reactivity of neurons to metabotropic glutamate receptor (mGlu) agonist (1S,3R)-1-carboxycyclopentane-3acetic acid (1S,3R-ACPD) were investigated in the rat hippocampal slices. The concentration-dependent increase in inositol phosphate accumulation in the slices from CA1 region of hippocampus induced by 1S,3R-ACPD was not modified by imipramine treatment. 1S,3R-ACPD produced a concentration-dependent increase in population spike amplitude recorded in the CA1 cell layer. This effect of 1S,3R-ACPD was markedly attenuated by repeated imipramine administration. Our results indicate that antidepressant treatment may induce a subsensitivity of mGlu receptors in the CA1 region of hippocampus when estimated by electrophysiological, but not biochemical measures.

MeSH terms

  • Animals
  • Antidepressive Agents, Tricyclic / pharmacology*
  • Cycloleucine / analogs & derivatives
  • Cycloleucine / pharmacology
  • Electrophysiology
  • Excitatory Amino Acid Agonists / pharmacology
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Imipramine / pharmacology*
  • Inositol Phosphates / biosynthesis
  • Male
  • Rats
  • Rats, Wistar
  • Receptors, Metabotropic Glutamate / drug effects*

Substances

  • Antidepressive Agents, Tricyclic
  • Excitatory Amino Acid Agonists
  • Inositol Phosphates
  • Receptors, Metabotropic Glutamate
  • Cycloleucine
  • 1-amino-1,3-dicarboxycyclopentane
  • Imipramine